Skip to content
Screener

USANA Health Sciences USNA Q4 2024 Annual earnings

Reported February 25, 2025 · After market close

Revenue$213.6MBeat by $4.8M
EPS$0.64Beat by $0.15
Revenue estimate$208.8M
EPS estimate$0.49

Next report

Oct 28, 2026 (in 3 months)
Revenue estimate$224.7M
EPS estimate$0.43

Financials

Q4 2024

Income statement

See full
Revenue$213.6M-3.4%
Gross profit$175.1M-2.1%
Operating income$8.2M-66.1%
Net income$4.5M-73.4%
EPS (diluted)$0.23-73.6%

Balance sheet

See full
Cash & equivalents$181.8M-45.0%
Total debt$16.2M+30.5%
Total equity$532.1M+7.0%
Total assets$748.2M+18.2%

Cash flow

See full
Operating cash flow$5.8M-77.8%
CapEx$1.8M-75.4%
Free cash flow$4.0M-78.7%

Valuation & ratios

Valuation

as of 12/28/24
See full
Market cap$620.77M-30.9%
Enterprise value$455.21M-21.5%
P/E14.8×+0.7×
P/S0.7×-0.2×

Profitability

See full
Gross margin81.1%+0.3pp
Operating margin7.8%-2.3pp
Net margin4.9%-2.0pp
FCF margin6%-0.1pp

Returns & leverage

See full
Return on equity8.2%-5.5pp
Debt / equity0×0.0×
Current ratio2×-1.5×

Segments

By geography

See full
Greater China$112.6M-2.9%
Americas and Europe$46.4M+5.6%
Southeast Asia Pacific$38.1M-2.7%
North Asia$16.5M-25.0%

By segment

See full
Hiya$492.5K—

FAQ

When did USANA Health Sciences report Q4 2024 earnings?
USANA Health Sciences (USNA) reported Q4 2024 earnings on February 25, 2025 after market close.
What were USANA Health Sciences's Q4 2024 revenue and EPS?
USANA Health Sciences reported revenue of $213.6M and eps of $0.64 for Q4 2024.
Did USANA Health Sciences beat estimates in Q4 2024?
Revenue beat the consensus estimate of $208.8M by $4.8M. EPS beat the consensus estimate of $0.49 by $0.15.
Where can I find USANA Health Sciences's Q4 2024 SEC filings?
You can read the 8-K earnings release (0000896264-25-000054) and the 10-K periodic report (0000896264-25-000092) directly on SEC EDGAR. The filing index links above go to sec.gov.